UCB SA (UCB.BR)

EUR 146.75

(4.67%)

Long Term Debt Summary of UCB SA

UCB SA's latest annual long term debt in 2023 was 2.87 Billion EUR , up 13.4% from previous year.
UCB SA's latest quarterly long term debt in 2024 Q2 was 2.84 Billion EUR , down 0.0% from previous quarter.
UCB SA reported annual long term debt of 2.53 Billion EUR in 2022, up 28.77% from previous year.
UCB SA reported annual long term debt of 1.97 Billion EUR in 2021, down -12.05% from previous year.
UCB SA reported quarterly long term debt of 2.87 Billion EUR for 2023 FY, up 13.4% from previous quarter.
UCB SA reported quarterly long term debt of 2.51 Billion EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of UCB SA (2023 - 2002)

Historical Annual Long Term Debt of UCB SA (2023 - 2002)

Year	Long Term Debt	Long Term Debt Growth
2023	2.87 Billion EUR	13.4%
2022	2.53 Billion EUR	28.77%
2021	1.97 Billion EUR	-12.05%
2020	2.24 Billion EUR	145.19%
2019	914 Million EUR	-28.98%
2018	1.28 Billion EUR	-15.94%
2017	1.53 Billion EUR	-3.77%
2016	1.59 Billion EUR	-3.58%
2015	1.65 Billion EUR	-5.06%
2014	1.73 Billion EUR	-13.75%
2013	2.01 Billion EUR	6.61%
2012	1.89 Billion EUR	6.66%
2011	1.77 Billion EUR	0.8%
2010	1.75 Billion EUR	4.83%
2009	1.67 Billion EUR	-15.98%
2008	1.99 Billion EUR	4.72%
2007	1.9 Billion EUR	-37.49%
2006	3.04 Billion EUR	197.75%
2005	1.02 Billion EUR	314.55%
2004	247.01 Million EUR	-19.74%
2003	307.78 Million EUR	0.0%
2002	- EUR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	2.84 Billion EUR	0.0%
2023 FY	2.87 Billion EUR	13.4%
2023 Q2	2.51 Billion EUR	0.0%
2023 Q4	2.87 Billion EUR	0.0%
2022 FY	2.53 Billion EUR	28.77%
2022 Q2	2.77 Billion EUR	0.0%
2022 Q4	2.53 Billion EUR	0.0%
2021 Q2	1.93 Billion EUR	0.0%
2021 Q4	1.97 Billion EUR	0.0%
2021 FY	1.97 Billion EUR	-12.05%
2020 Q4	2.24 Billion EUR	0.0%
2020 Q2	2.38 Billion EUR	0.0%
2020 FY	2.24 Billion EUR	145.19%
2019 Q4	914 Million EUR	0.0%
2019 FY	914 Million EUR	-28.98%
2019 Q2	928 Million EUR	0.0%
2018 Q4	1.28 Billion EUR	0.0%
2018 FY	1.28 Billion EUR	-15.94%
2018 Q2	1.37 Billion EUR	0.0%
2017 FY	1.53 Billion EUR	-3.77%
2017 Q2	1.54 Billion EUR	0.0%
2017 Q4	1.53 Billion EUR	0.0%
2016 Q4	1.59 Billion EUR	0.0%
2016 FY	1.59 Billion EUR	-3.58%
2016 Q2	1.59 Billion EUR	0.0%
2015 Q4	1.65 Billion EUR	0.0%
2015 Q2	2.07 Billion EUR	0.0%
2015 FY	1.65 Billion EUR	-5.06%
2014 Q2	1.64 Billion EUR	0.0%
2014 FY	1.73 Billion EUR	-13.75%
2014 Q4	1.73 Billion EUR	0.0%
2013 Q4	2.02 Billion EUR	0.0%
2013 FY	2.01 Billion EUR	6.61%
2013 Q2	2.23 Billion EUR	0.0%
2012 Q2	1.87 Billion EUR	0.0%
2012 FY	1.89 Billion EUR	6.66%
2012 Q4	1.89 Billion EUR	0.0%
2011 Q4	1.77 Billion EUR	0.0%
2011 Q2	1.72 Billion EUR	0.0%
2011 FY	1.77 Billion EUR	0.8%
2010 FY	1.75 Billion EUR	4.83%
2010 Q4	1.75 Billion EUR	0.0%
2010 Q2	1.72 Billion EUR	0.0%
2009 Q4	1.67 Billion EUR	0.0%
2009 FY	1.67 Billion EUR	-15.98%
2008 FY	1.99 Billion EUR	4.72%
2007 FY	1.9 Billion EUR	-37.49%
2006 FY	3.04 Billion EUR	197.75%
2005 FY	1.02 Billion EUR	314.55%
2004 FY	247.01 Million EUR	-19.74%
2003 FY	307.78 Million EUR	0.0%
2002 FY	- EUR	0.0%

Peer Long Term Debt Comparison of UCB SA

Name	Long Term Debt	Long Term Debt Difference
Nicox S.A.	25.15 Million EUR	-11341.975%
European Medical Solutions	12.71 Million EUR	-22532.903%
FERMENTALG	14.33 Million EUR	-19972.535%
argenx SE	15.35 Million EUR	-18644.301%
BioSenic S.A.	15.57 Million EUR	-18380.704%
Celyad Oncology SA	902 Thousand EUR	-318968.736%
Hyloris Pharmaceuticals SA	344 Thousand EUR	-836527.907%
Onward Medical N.V.	16.3 Million EUR	-17549.945%
Oxurion NV	117 Thousand EUR	-2459729.06%
PHAXIAM Therapeutics S.A.	7.03 Million EUR	-40838.834%
Financière de Tubize SA	- EUR	-Infinity%